An Alcohol Cross-Tolerance Experiment Used WIN 55,212-2, Not THC
Repeated alcohol exposure reduced selected responses to a synthetic cannabinoid in mice. That result cannot be restated as proof that people who drink heavily are protected from marijuana’s effects.
The tested cannabinoid matters
Male mice received ethanol twice daily for ten days before a challenge with WIN 55,212-2. WIN is an experimental cannabinoid-receptor agonist, not delta-9 THC or whole-plant cannabis. The study assessed locomotion, responses to painful heat, body temperature and catalepsy.
Three outcomes changed; one did not
Prior ethanol reduced WIN-related suppression of movement, antinociception and hypothermia. Catalepsy did not show the same significant change. After a further ten-day recovery period, the measured sensitivity differences were no longer significant. These findings describe selected behavioral responses and a particular observation window.
Brain results were regional
The investigators measured CB1 protein in dissected brain regions. Changes differed by region rather than showing a uniform whole-brain decrease. These tissue measurements were not blood THC concentrations and did not provide an individual impairment threshold.
Cross-tolerance has a direction
The experiment tested ethanol history followed by a cannabinoid challenge. It did not establish the reverse relationship or test simultaneous alcohol–THC exposure in drivers. Species, injected dosing, agonist efficacy and the specific tasks restrict translation. A sound opinion names both drugs, the direction of exposure and the endpoint instead of using cross-tolerance as a blanket assurance of preserved function.
Related analysis: the separate human alcohol–cannabis attention experiment.
Primary research
Pava MJ; Blake EM; Green ST; Mizroch BJ; Mulholland PJ; Woodward JJ. Tolerance to cannabinoid-induced behaviors in mice treated chronically with ethanol. Psychopharmacology (2012). DOI: 10.1007/s00213-011-2387-0.
